Plecanatide vs Met-enkephalin
Head-to-head comparison of Plecanatide (Plecanatide) and Met-enkephalin (Tyr-Gly-Gly-Phe-Met) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Plecanatide | Met-enkephalin |
|---|---|---|
| Category | Gastrointestinal | Pain Management |
| Full Name | Plecanatide | Tyr-Gly-Gly-Phe-Met |
| Molecular Weight | Approx. 1620 Da | 573.67 Da |
| Half-Life | Local intestinal action; systemic half-life not clinically meaningful | 1-5 minutes in plasma |
| Amino Acids | 16 | 5 |
| Typical Dose | 3 mg once daily | 0.1-5 ug per animal |
| Route | Oral | Intrathecal / intracerebroventricular |
| Purity | ≥98% | ≥98% |
| Studies Count | 350 | 1200 |
| Research Status | Clinical | Pre-clinical |
Plecanatide Benefits
- ✓improves-stool-frequency
- ✓supports-fluid-secretion
- ✓may-reduce-constipation
- ✓local-gut-action
Met-enkephalin Benefits
- ✓endogenous opioid signaling
- ✓analgesic reference ligand
- ✓spinal antinociception
- ✓neurochemical pain-pathway probe
Plecanatide Dosing
3 mg PO daily|take with or without food|avoid when dehydrated
Met-enkephalin Dosing
Intrathecal 0.1-5 ug per animal|Intracerebroventricular 0.1-2 ug per animal|In vitro 1-100 nM
Plecanatide Side Effects
- ⚠diarrhea
- ⚠abdominal-discomfort
- ⚠nausea
Met-enkephalin Side Effects
- ⚠sedation at higher exposure
- ⚠constipation-like opioid effects
- ⚠rapid enzymatic degradation
Research Overview
Plecanatide
Clinical trials show plecanatide improves constipation outcomes with a generally favorable tolerability profile. Like linaclotide, it acts locally in the intestinal lumen via GC-C signaling rather than systemic hormone effects.
Met-enkephalin
Met-enkephalin has been extensively used in receptor pharmacology and nociception studies to map mu and delta opioid biology. The main limitation in translational work is very short half-life from peptidase cleavage and poor systemic stability.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.